Published in Women's Health Weekly, April 14th, 2005
The study was designed to compare the pharmacokinetic profile of 8 mg of the ondansetron lingual spray to an 8 mg oral tablet of Zofran. The study achieved its goal of demonstrating the ability to deliver ondansetron via the lingual spray technology and produce a similar pharmacokinetic profile to the currently marketed oral tablet, with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly